Combating Parkinson's disease with plant-derived polyphenols: Targeting oxidative stress and neuroinflammation
- PMID: 38950626
- DOI: 10.1016/j.neuint.2024.105798
Combating Parkinson's disease with plant-derived polyphenols: Targeting oxidative stress and neuroinflammation
Abstract
Parkinson's disease (PD) is a devastating neurodegenerative disorder predominantly affecting the elderly, characterized by the loss of dopaminergic neurons in the substantia nigra. Reactive oxygen species (ROS) generation plays a central role in the pathogenesis of PD and other neurodegenerative diseases. An imbalance between cellular antioxidant activity and ROS production leads to oxidative stress, contributing to disease progression. Dopamine metabolism, mitochondrial dysfunction, and neuroinflammation in dopaminergic neurons have been implicated in the pathogenesis of Parkinson's disease. Consequently, there is a pressing need for therapeutic interventions capable of scavenging ROS. Current pharmacological approaches, such as L-dihydroxyphenylalanine (levodopa or L-DOPA) and other drugs, provide symptomatic relief but are limited by severe side effects. Researchers worldwide have been exploring alternative compounds with less toxicity to address the multifaceted challenges associated with Parkinson's disease. In recent years, plant-derived polyphenolic compounds have gained significant attention as potential therapeutic agents. These compounds exhibit neuroprotective effects by targeting pathophysiological responses, including oxidative stress and neuroinflammation, in Parkinson's disease. The objective of this review is to summarize the current understanding of the neuroprotective effects of various polyphenols in Parkinson's disease, focusing on their antioxidant and anti-inflammatory properties, and to discuss their potential as therapeutic candidates. This review highlights the progress made in elucidating the molecular mechanisms of action of these polyphenols, identifying potential therapeutic targets, and optimizing their delivery and bioavailability. Well-designed clinical trials are necessary to establish the efficacy and safety of polyphenol-based interventions in the management of Parkinson's disease.
Keywords: Inflammation; Natural medicine; Oxidative stress; Parkinson's disease; polyphenols.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress.Curr Drug Targets. 2020;21(5):458-476. doi: 10.2174/1389450120666191017120505. Curr Drug Targets. 2020. PMID: 31625473 Review.
-
Repositioning the existing drugs for neuroinflammation: a fusion of computational approach and biological validation to counter the Parkinson's disease progression.Mol Divers. 2024 Oct;28(5):2759-2770. doi: 10.1007/s11030-023-10708-5. Epub 2023 Aug 4. Mol Divers. 2024. PMID: 37542020
-
Abrogating Oxidative Stress as a Therapeutic Strategy Against Parkinson's Disease: A Mini Review of the Recent Advances on Natural Therapeutic Antioxidant and Neuroprotective Agents.Med Chem. 2022;18(7):772-783. doi: 10.2174/1573406418666220304222401. Med Chem. 2022. PMID: 35249501 Review.
-
Promising Polyphenols in Parkinson's Disease Therapeutics.Neurochem Res. 2020 Aug;45(8):1731-1745. doi: 10.1007/s11064-020-03058-3. Epub 2020 May 27. Neurochem Res. 2020. PMID: 32462543 Review.
-
Role of Glutathione in Parkinson's Disease Pathophysiology and Therapeutic Potential of Polyphenols.Phytother Res. 2024 Dec;38(12):5567-5582. doi: 10.1002/ptr.8342. Epub 2024 Sep 17. Phytother Res. 2024. PMID: 39290049 Review.
Cited by
-
Xifeng Jiannao pill mitigates MPTP-induced neuronal apoptosis by reducing inflammation and oxidative stress via MAPK signaling.Metab Brain Dis. 2025 Apr 4;40(4):170. doi: 10.1007/s11011-025-01597-8. Metab Brain Dis. 2025. PMID: 40183980 Free PMC article.
-
Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives.CNS Neurosci Ther. 2025 Aug;31(8):e70540. doi: 10.1111/cns.70540. CNS Neurosci Ther. 2025. PMID: 40808332 Free PMC article. Review.
-
Redox Homeostasis, Gut Microbiota, and Epigenetics in Neurodegenerative Diseases: A Systematic Review.Antioxidants (Basel). 2024 Aug 30;13(9):1062. doi: 10.3390/antiox13091062. Antioxidants (Basel). 2024. PMID: 39334720 Free PMC article. Review.
-
The role of Panax ginseng in neurodegenerative disorders: mechanisms, benefits, and future directions.Metab Brain Dis. 2025 Apr 15;40(4):183. doi: 10.1007/s11011-025-01610-0. Metab Brain Dis. 2025. PMID: 40232582 Review.
-
Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review.Front Pharmacol. 2025 Jan 24;16:1492517. doi: 10.3389/fphar.2025.1492517. eCollection 2025. Front Pharmacol. 2025. PMID: 39981183 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical